Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there ...

Key market opportunities in the prefilled syringe fill finish sector include the rise in demand for self-medication, outsourcing of fill/finish operations to address technical challenges, and ...

May 12 (UPI) --The Department of Defense announced Tuesday that it has awarded a $138 million contract to ApiJect Systems America to create a ready supply chain for prefilled syringes when a COVID-19 ...

Novel patented syringe system offers safety and convenience for patients RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter today has announced the release of Vetter-Ject ®, a novel closure system for ...

The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organization is building a state-of-the-art, high-performance ...

NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable self-administration, automation in fill–finish ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Credence MedSystems, Inc. announced today the launch of the Credence Companion Safety Syringe System at two upcoming conferences focused on drug delivery solutions ...

On May 12, the Defense Department and the Health and Human Services Department issued a $138 million contract to ApiJect Systems America to coordinate the production of prefilled syringes in ...

Key market opportunities in the Prefilled Syringes Market include rapid growth driven by GLP-1 obesity therapeutics and rising self-injection demand, preference for COP over glass to mitigate ...

Statement attributed to Lt. Col. Mike Andrews, Department of Defense spokesman: “Today the Department of Defense and the U.S. Department of Health and Human Services, announce a $138 million contract ...

The US Food and Drug Administration (FDA) has rejected a prefilled syringe version of Regeneron's ophthalmology blockbuster Eylea HD (aflibercept), as manufacturing shortcomings continue to plague the ...